Product NDC: | 50474-710 |
Proprietary Name: | Cimzia |
Non Proprietary Name: | certolizumab pegol |
Active Ingredient(s): | 200 mg/mL & nbsp; certolizumab pegol |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50474-710 |
Labeler Name: | UCB, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125160 |
Marketing Category: | BLA |
Start Marketing Date: | 20090514 |
Package NDC: | 50474-710-81 |
Package Description: | 3 CARTON in 1 BOX (50474-710-81) > 2 SYRINGE, GLASS in 1 CARTON > 1 mL in 1 SYRINGE, GLASS |
NDC Code | 50474-710-81 |
Proprietary Name | Cimzia |
Package Description | 3 CARTON in 1 BOX (50474-710-81) > 2 SYRINGE, GLASS in 1 CARTON > 1 mL in 1 SYRINGE, GLASS |
Product NDC | 50474-710 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | certolizumab pegol |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20090514 |
Marketing Category Name | BLA |
Labeler Name | UCB, Inc. |
Substance Name | CERTOLIZUMAB PEGOL |
Strength Number | 200 |
Strength Unit | mg/mL |
Pharmaceutical Classes |